Guideline Recommendations for Chronic Bacterial Prostatitis (CBP)
Microbiologic Spectrum of CBP
- The European Association of Urology (EAU) 2024 guidelines state that chronic bacterial prostatitis exhibits a broader microbiologic spectrum than acute prostatitis, frequently involving atypical pathogens beyond the Enterobacterales family. Strength of evidence: moderate. 1, 2, 3
Recognition of Enterococci as Pathogens
- The EAU 2024 guidelines explicitly recognize enterococci, including Enterococcus faecalis, as legitimate pathogens in CBP and advise that microbiologic work‑up should specifically target atypical organisms such as Chlamydia trachomatis and Mycoplasma species. Strength of recommendation: strong. 4, 5, 6
Diagnostic Testing Recommendations
| Test | Recommended Specimen Strategy | Recommendation Strength |
|---|---|---|
| Meares‑Stamey (pre‑ and post‑massage urine cultures) | Perform 2‑ or 4‑specimen protocol in patients with suspected CBP | Strong |
| Routine semen culture alone | Do not use as a standalone diagnostic tool for CBP | Strong |
Both recommendations are endorsed by the EAU 2024 guidelines. 4, 5, 6, 7, 8
Evaluation for Atypical Pathogens
- In patients with risk factors for atypical infections, the EAU 2024 guidelines recommend nucleic‑acid amplification testing (NAAT) for Chlamydia trachomatis and Mycoplasma species to ensure comprehensive microbiologic assessment. Strength of recommendation: strong. 4, 5, 6
Imaging for Complicated Cases
- When a prostatic abscess is clinically suspected, the EAU 2024 guidelines advise performing a trans‑rectal ultrasound (TRUS) to confirm the diagnosis. Strength of recommendation: strong. 4, 5, 6, 7, 8
Consideration of Non‑Infectious Chronic Pelvic Pain
- The EAU 2024 guidelines note that chronic pelvic pain syndrome/chronic prostatitis (CP/CPPS) accounts for more than 90 % of all prostatitis diagnoses, highlighting the importance of distinguishing infectious CBP from CP/CPPS when symptoms persist despite microbiologic eradication. Strength of evidence: moderate. 1, 2, 3
Assessment for Genitourinary Tuberculosis
- For patients presenting with risk factors (e.g., diabetes, immunosuppression, residence in endemic regions, persistent nonspecific urologic symptoms), the EAU 2024 guidelines recommend evaluating for genitourinary tuberculosis as a potential underlying cause of chronic prostatitis‑like symptoms. Strength of recommendation: strong. 4, 5, 6, 7